Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · May 15, 2024

Safety Profile of and Patient Preference for Shorter Ocrelizumab Infusion

Journal of Neurology


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Neurology
ENSEMBLE PLUS: final results of shorter ocrelizumab infusion from a randomized controlled trial
J Neurol 2024 Apr 22;[EPub Ahead of Print], HP Hartung, T Berger, RA Bermel, B Brochet, WM Carroll, T Holmøy, R Karabudak, J Killestein, C Nos, F Patti, A Perrin Ross, L Vanopdenbosch, T Vollmer, R Buffels, M Garas, K Kadner, M Manfrini, Q Wang, MS Freedman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading